JEAN-JACQUES

CARRE
Image

Why Market Access and Public Affairs?


"Healthcare products must go through rigorous approval processes before they are allowed on the market. Detailed knowledge of these processes is necessary... but not sufficient!
Knowing who's involved with the authorities, and having experience of negotiating with them are all keys to controlling delays, costs and the associated risks."

Why IDM+?


"IDM+ brings together all the expertise required to support companies in the healthcare sector. Not only scientific, but also operational expertise. This complementarity, which enables us to cover all the essential issues faced by companies operating in the healthcare sector, appealed to me, as I'm certain we can bring undeniable added value and a guarantee of efficiency to the companies we support, through this new collegial approach to market access issues. "

30 years' experience in the DM industry

Positions as Marketing and Sales Director, BU Director, Scientific and Medical Director, member of the Executive Committee at world leaders in DM.

SNITEM

Vice-Chairman and Director for 10 years, in charge of tariff negotiations with CEPS for the orthopedic sector.

BPI France expert

Digital health for the I Lab, I NOV and I DEMO AAPs as part of the France 2030 stimulus plan.

Sciences Po

Lecturer at the Health Chair.

CARRE CONSULTING

Founder and CEO.

CONTACT